New European “Guidelines for the Management of Severe Perioperative Bleeding” Consider Hemoadsorption for the First-Time
07 mars 2023 07h00 HE
|
CytoSorbents
PRINCETON, N.J., March 07, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
CytoSorbents Appoints Dr. Rainer Kosanke as European Director of Scientific Affairs
08 juil. 2013 09h00 HE
|
CytoSorbents
MONMOUTH JUNCTION, N.J., July 8, 2013 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (OTCBB:CTSO), a critical care focused company commercializing its European Union approved CytoSorb® blood filter...
CytoSorbents Announces Start of $1M US Army Phase II SBIR Contract and Closing of Additional Funding
27 juin 2013 09h00 HE
|
CytoSorbents
MONMOUTH JUNCTION, N.J., June 27, 2013 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (OTCBB: CTSO), a critical care focused
company commercializing its European Union approved CytoSorb®...
CytoSorbents Announces FDA Approved US Air Force Funded Human Trauma Pilot Study for Rhabdomyolysis
17 juin 2013 08h00 HE
|
CytoSorbents
MONMOUTH JUNCTION, N.J., June 17, 2013 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (OTCBB:CTSO), a critical care focused company using blood purification to treat life-threatening illnesses in the...
CytoSorbents Enters Into Exclusive Distribution Agreement for CytoSorb(R) With Hitit Medical Systems in Turkey
13 juin 2013 09h00 HE
|
CytoSorbents
MONMOUTH JUNCTION, N.J., June 13, 2013 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (OTCBB:CTSO), a critical care focused therapeutic device company using blood purification to treat life-threatening...
CytoSorbents Reports 2013 First Quarter Financial Results
16 mai 2013 07h00 HE
|
CytoSorbents
MONMOUTH JUNCTION, N.J., May 16, 2013 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (OTCBB:CTSO) is a critical care focused company using blood purification to treat life-threatening illnesses in the...
Kathleen P. Bloch Appointed as Chief Financial Officer of CytoSorbents
13 mai 2013 08h00 HE
|
CytoSorbents
MONMOUTH JUNCTION, N.J., May 13, 2013 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (OTCBB:CTSO), a critical care focused therapeutic device company using blood purification to treat life-threatening...
CytoSorbents Enters Into Exclusive Distribution Agreement for CytoSorb(R) With L.IN.C. Medical Systems in the United Kingdom and Ireland
06 mai 2013 08h01 HE
|
CytoSorbents
MONMOUTH JUNCTION, N.J., May 6, 2013 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (OTCBB:CTSO), a critical care focused therapeutic device company using blood purification to treat life-threatening...
CytoSorbents CEO Provides Exclusive Interview With medGadget
01 mai 2013 09h30 HE
|
CytoSorbents
MONMOUTH JUNCTION, N.J., May 1, 2013 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (OTCBB:CTSO), a critical care-focused company using blood purification to treat life-threatening illnesses, announced...
CytoSorbents Appoints Christopher Cramer as Vice President of Business Development
15 avr. 2013 08h00 HE
|
CytoSorbents
MONMOUTH JUNCTION, N.J., April 15, 2013 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (OTCBB:CTSO), a critical care-focused company using blood purification to treat life-threatening illnesses in the...